Change search
ReferencesLink to record
Permanent link

Direct link
Engineering bispecificityinto a single albumin-binding domain aimed for drug-targeting and extended in vivo half-life extension.
KTH, School of Biotechnology (BIO), Proteomics.
KTH, School of Biotechnology (BIO), Proteomics.ORCID iD: 0000-0002-6104-6446
KTH, School of Biotechnology (BIO), Proteomics.ORCID iD: 0000-0003-0605-8417
KTH, School of Biotechnology (BIO), Proteomics.ORCID iD: 0000-0001-9423-0541
(English)Manuscript (preprint) (Other academic)
URN: urn:nbn:se:kth:diva-12818OAI: diva2:319019


Available from: 2010-05-12 Created: 2010-05-12 Last updated: 2012-09-20Bibliographically approved
In thesis
1. Interaction engineered three-helix bundle domains for protein recovery and detection
Open this publication in new window or tab >>Interaction engineered three-helix bundle domains for protein recovery and detection
2010 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

HTML clipboard The great advances in DNA technology, e.g. sequencing and recombinant DNA techniques, have given us the genetic information and the tools needed to effectively produce recombinant proteins. Recombinant proteins are valuable means in biotechnological applications and are also emerging as alternatives in therapeutic applications. Traditionally, monoclonal antibodies have been the natural choice for biotechnological and therapeutic applications due to their ability to bind a huge range of different molecules and their natural good affinity. However, the large size of antibodies (150 kDa) limits tissue penetration and the recombinant expression is complicated. Therefore, alternative binders with smaller sizes have been derived from antibodies and alternative scaffolds.

In this thesis, two structurally similar domains, Zbasic and ABDz1, have been used as purification tags in different contexts. They are both three-helical bundles and derived from bacterial surface domains, but share no sequence homology. Furthermore, by redesign of the scaffold used for ABDz1, a molecule intended for drug targeting with extended in-vivo half-life has been engineered. In Papers I and II, the poly-cationic tag Zbasic is explored and evaluated. Paper I describes the successful investigation of Zbasic as a purification handle under denaturating conditions. Moreover, Zbasic is evaluated as an interaction domain in matrixassisted refolding. Two different proteins were successfully refolded using the same setup without individual optimization. In Paper II, Zbasic is further explored as a purification handle under non-native conditions in a multi-parallel setup. In total, 22 proteins with varying characteristics are successfully purified using a multi-parallel protein purification protocol and a robotic system. Without modifications, the system can purify up to 60 proteins without manual handling. Paper I and II clearly demonstrate that Zbasic can be used as an interaction domain in matrix-assisted refolding and that it offers a good alternative to the commonly used His6-tag under denaturating conditions. In paper III, the small bifunctional ABDz1 is selected from a phage display library. Endowed with two different binding interfaces, ABDz1 is capable of binding both the HSA-sepharose and the protein A-derived MabSelect SuRe-matrix. The bifunctionality of the domain is exploited in an orthogonal affinity setup. Three target proteins are successfully purified using the HSA-matrix and the MabSelect SuRe-matrix. Furthermore, the purity of the target proteins is effectively improved by combining the two chromatographic steps. Thus, paper III shows that the small ABDz1 can be used as an effective purification handle and dual affinity tag without target specific optimization. Paper IV describes the selection and affinity maturation of small bispecific drug-targeting molecules. First generation binders against tumor necrosis factor-α are selected using phage display. Thereafter on-cell surface display and flow cytometry is used to select second-generation binders. The binding to tumor necrosis factor-α is improved up to 30 times as compared to the best first generation binder, and a 6-fold improvement of the binding strength was possible with retained HSA affinity. Paper III and IV clearly demonstrate that dual interaction surfaces can successfully be grafted on a small proteinaceous domain, and that the strategy in paper IV can be used for dual selection of bifunctional binders.

Place, publisher, year, edition, pages
Stockholm: KTH, 2010. x, 79 p.
Trita-BIO-Report, ISSN 1654-2312 ; 2010:5
ABD, Zbasic, albumin, protein engineering, phage display, staphylococcal display, inclusion bodies, refolding, proteomics, orthogonal affinity purification
National Category
Industrial Biotechnology Other Industrial Biotechnology
urn:nbn:se:kth:diva-12823 (URN)978-91-7415-601-0 (ISBN)
Public defence
2010-05-28, D2, entréplan, Lindstedtsvägen 5, KTH, Stockholm, 10:00 (English)


Available from: 2010-05-12 Created: 2010-05-12 Last updated: 2012-11-21Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Alm, ToveNilvebrant, JohanHober, SophiaLöfblom, John
By organisation

Search outside of DiVA

GoogleGoogle ScholarTotal: 337 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 72 hits
ReferencesLink to record
Permanent link

Direct link